RGEN : Repligen stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-28 |
|---|---|---|---|---|
| 2026 | $173.12 | $119.22 | $239.6 | 41.05% |
| 2027 | $328.84 | $262.9 | $363.29 | 167.94% |
| 2028 | $374.15 | $362.1 | $383.08 | 204.86% |
| 2029 | $294.95 | $179.3 | $358.43 | 140.32% |
| 2030 | $185.55 | $130.74 | $219.88 | 51.19% |
| 2031 | $157.25 | $147.82 | $174.08 | 28.13% |
| 2032 | $160.32 | $147.98 | $170.7 | 30.63% |
| 2033 | $286.07 | $175.21 | $364.04 | 133.09% |
| 2034 | $383.47 | $360.91 | $417.31 | 212.45% |
| 2035 | $390.22 | $352.16 | $415.76 | 217.95% |
| 2036 | $268.28 | $203.39 | $331.02 | 118.59% |
The 15 Wall Street analysts offering Repligen stock forecast in the last 6 months have average price target of
$172.87 with a high forecast of $208.0 and a low forecast of $140.0.
The average Repligen stock forecast represents a 40.85%
increase from the last price of $122.7300033569336.
For Repligen stock forecast for 2026, 7 predictions are offered for each month of 2026 with average Repligen stock
forecast of $173.12, a high forecast of $239.6, and a low forecast of $119.22.
The average Repligen stock forecast 2026 represents a 41.05%
increase from the last price of $122.7300033569336.
For Repligen stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Repligen stock
forecast of $328.84, a high forecast of $363.29, and a low forecast of $262.9.
The average Repligen stock forecast 2027 represents a 167.94%
increase from the last price of $122.7300033569336.
For Repligen stock forecast for 2029, 12 predictions are offered for each month of 2029 with average Repligen stock
forecast of $294.95, a high forecast of $358.43, and a low forecast of $179.3.
The average Repligen stock forecast 2029 represents a 140.32%
increase from the last price of $122.7300033569336.
For Repligen stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average Repligen stock
forecast of $157.25, a high forecast of $174.08, and a low forecast of $147.82.
The average Repligen stock forecast 2031 represents a 28.13%
increase from the last price of $122.7300033569336.
For Repligen stock forecast 2032, 12 predictions are offered for each month of 2032 with average Repligen stock
forecast of $160.32, a high forecast of $170.7, and a low forecast of $147.98.
The average Repligen stock forecast 2032 represents a 30.63%
increase from the last price of $122.7300033569336.
For Repligen stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average Repligen stock
forecast of $268.28, a high forecast of $331.02, and a low forecast of $203.39.
The average Repligen stock forecast 2036 represents a 118.59%
increase from the last price of $122.7300033569336.
Please, see more forecasts below.
RGEN : Repligen stock forecast by Wall Street Analysts
The average Repligen stock forecast from last 6 month is $172.87, and this show a -2.24% decrease in average from the prior price target of the each prediction. Also, this average forecast of $172.87 represents a 6.3% increase from the past average forecast of $162.62, 6 months ago from 13 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-15 | RBC Capital | $160.0000 | Outperform | |
| 2026-05-06 | Barclays | $145.00 | $160.0000 | Overweight |
| 2026-05-06 | JP Morgan | $180.0000 | $165.0000 | Overweight |
| 2026-04-20 | Canaccord Genuity | $165.00 | $145.0000 | Hold |
| 2026-04-17 | Roth Capital | $160.0000 | Buy | |
| 2026-04-14 | Barclays | $175.00 | $145.0000 | Overweight |
| 2026-04-06 | Evercore ISI Group | $170.00 | $140.0000 | Outperform |
| 2026-03-23 | HC Wainwright & Co. | $180.0000 | $208.0000 | Buy |
| 2026-02-25 | Evercore ISI Group | $180.0000 | $170.0000 | Outperform |
| 2026-02-25 | Wells Fargo | $190.00 | $180.0000 | Overweight |
| 2026-02-25 | Barclays | $200.00 | $175.0000 | Overweight |
| 2026-02-25 | UBS | $200.00 | $195.0000 | Buy |
| 2026-01-16 | UBS | $190.0000 | $200.0000 | Buy |
| 2025-12-15 | Wells Fargo | $175.00 | $190.0000 | Overweight |
| 2025-12-15 | Barclays | $175.00 | $200.0000 | Overweight |
| 2025-10-29 | Barclays | $160.00 | $175.0000 | Overweight |
| 2025-10-29 | Canaccord Genuity | $150.00 | $165 | Hold |
| 2025-10-07 | Evercore ISI Group | $155.00 | $175.0000 | Outperform |
| 2025-10-02 | Barclays | $150.00 | $160.0000 | Overweight |
| 2025-10-01 | HSBC | $150.0000 | Buy | |
| 2025-09-22 | Evercore ISI Group | $130.00 | $155.0000 | Outperform |
| 2025-09-12 | Jefferies | $145.0000 | $135 | Hold |
| 2025-09-03 | HC Wainwright & Co. | $180.00 | $180.0000 | Buy |
| 2025-07-30 | Wells Fargo | $180.00 | $175.0000 | Overweight |
| 2025-07-30 | RBC Capital | $193.0000 | $204.0000 | Outperform |
| 2025-07-22 | Stephens & Co. | $160.0000 | Overweight | |
| 2025-07-08 | Evercore ISI Group | $140.0000 | $130 | In-Line |
| 2025-06-24 | Barclays | $150.0000 | Overweight |
Repligen stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-29 | $124.22 | 1.21% |
| 2026-06-01 | $123.96 | -0.21% |
| 2026-06-02 | $122.93 | -0.83% |
| 2026-06-03 | $123.62 | 0.56% |
| 2026-06-04 | $125.67 | 1.66% |
RGEN : Long term Repligen stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $119.22 , for 2027 May. is $328.21 , for 2030 May. is $195.63 , for 2031 May. is $159.94 , for 2035 May. is $400.74 , and for 2036 May. is $203.39.
RGEN : Repligen stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $119.22 | -2.86% |
| 2026 Jul. | $132.16 | 10.85% |
| 2026 Aug. | $148.81 | 12.60% |
| 2026 Sep. | $168.04 | 12.92% |
| 2026 Oct. | $190.44 | 13.33% |
| 2026 Nov. | $213.56 | 12.14% |
| 2026 Dec. | $239.60 | 12.19% |
RGEN : Repligen stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $262.90 | 9.73% |
| 2027 Feb. | $284.69 | 8.28% |
| 2027 Mar. | $302.27 | 6.18% |
| 2027 Apr. | $317.01 | 4.88% |
| 2027 May. | $328.21 | 3.53% |
| 2027 Jun. | $337.06 | 2.70% |
| 2027 Jul. | $342.63 | 1.65% |
| 2027 Aug. | $346.54 | 1.14% |
| 2027 Sep. | $350.05 | 1.01% |
| 2027 Oct. | $353.74 | 1.05% |
| 2027 Nov. | $357.72 | 1.13% |
| 2027 Dec. | $363.29 | 1.56% |
RGEN : Repligen stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $370.86 | 2.08% |
| 2028 Feb. | $376.38 | 1.49% |
| 2028 Mar. | $381.75 | 1.43% |
| 2028 Apr. | $383.08 | 0.35% |
| 2028 May. | $381.49 | -0.41% |
| 2028 Jun. | $379.51 | -0.52% |
| 2028 Jul. | $377.78 | -0.45% |
| 2028 Aug. | $375.53 | -0.60% |
| 2028 Sep. | $371.35 | -1.11% |
| 2028 Oct. | $366.16 | -1.40% |
| 2028 Nov. | $362.10 | -1.11% |
| 2028 Dec. | $363.81 | 0.47% |
RGEN : Repligen stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $358.43 | -1.48% |
| 2029 Feb. | $352.83 | -1.56% |
| 2029 Mar. | $343.62 | -2.61% |
| 2029 Apr. | $336.16 | -2.17% |
| 2029 May. | $328.99 | -2.13% |
| 2029 Jun. | $320.69 | -2.52% |
| 2029 Jul. | $309.24 | -3.57% |
| 2029 Aug. | $293.73 | -5.01% |
| 2029 Sep. | $271.11 | -7.70% |
| 2029 Oct. | $239.74 | -11.57% |
| 2029 Nov. | $205.56 | -14.26% |
| 2029 Dec. | $179.30 | -12.78% |
RGEN : Repligen stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $161.90 | -9.70% |
| 2030 Feb. | $147.71 | -8.77% |
| 2030 Mar. | $137.44 | -6.95% |
| 2030 Apr. | $130.74 | -4.88% |
| 2030 May. | $195.63 | 49.63% |
| 2030 Jun. | $201.79 | 3.15% |
| 2030 Jul. | $210.29 | 4.21% |
| 2030 Aug. | $218.32 | 3.82% |
| 2030 Sep. | $219.88 | 0.71% |
| 2030 Oct. | $214.71 | -2.35% |
| 2030 Nov. | $202.29 | -5.79% |
| 2030 Dec. | $185.91 | -8.10% |
RGEN : Repligen stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $174.08 | -6.36% |
| 2031 Feb. | $166.49 | -4.36% |
| 2031 Mar. | $156.78 | -5.84% |
| 2031 Apr. | $155.26 | -0.97% |
| 2031 May. | $159.94 | 3.02% |
| 2031 Jun. | $160.00 | 0.03% |
| 2031 Jul. | $158.26 | -1.09% |
| 2031 Aug. | $155.69 | -1.62% |
| 2031 Sep. | $153.08 | -1.68% |
| 2031 Oct. | $150.67 | -1.57% |
| 2031 Nov. | $148.93 | -1.15% |
| 2031 Dec. | $147.82 | -0.75% |
RGEN : Repligen stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $147.98 | 0.11% |
| 2032 Feb. | $150.54 | 1.73% |
| 2032 Mar. | $154.38 | 2.55% |
| 2032 Apr. | $156.94 | 1.66% |
| 2032 May. | $158.34 | 0.89% |
| 2032 Jun. | $159.52 | 0.74% |
| 2032 Jul. | $161.08 | 0.98% |
| 2032 Aug. | $163.11 | 1.25% |
| 2032 Sep. | $165.33 | 1.36% |
| 2032 Oct. | $167.22 | 1.15% |
| 2032 Nov. | $168.72 | 0.90% |
| 2032 Dec. | $170.70 | 1.17% |
RGEN : Repligen stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $175.21 | 2.65% |
| 2033 Feb. | $185.65 | 5.96% |
| 2033 Mar. | $199.06 | 7.22% |
| 2033 Apr. | $220.29 | 10.67% |
| 2033 May. | $249.41 | 13.22% |
| 2033 Jun. | $284.36 | 14.01% |
| 2033 Jul. | $319.58 | 12.39% |
| 2033 Aug. | $347.33 | 8.68% |
| 2033 Sep. | $360.70 | 3.85% |
| 2033 Oct. | $363.53 | 0.79% |
| 2033 Nov. | $363.71 | 0.05% |
| 2033 Dec. | $364.04 | 0.09% |
RGEN : Repligen stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $365.24 | 0.33% |
| 2034 Feb. | $365.59 | 0.10% |
| 2034 Mar. | $364.28 | -0.36% |
| 2034 Apr. | $360.91 | -0.93% |
| 2034 May. | $361.39 | 0.13% |
| 2034 Jun. | $368.37 | 1.93% |
| 2034 Jul. | $377.72 | 2.54% |
| 2034 Aug. | $389.47 | 3.11% |
| 2034 Sep. | $401.63 | 3.12% |
| 2034 Oct. | $412.91 | 2.81% |
| 2034 Nov. | $417.31 | 1.06% |
| 2034 Dec. | $416.87 | -0.10% |
RGEN : Repligen stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $415.76 | -0.27% |
| 2035 Feb. | $413.73 | -0.49% |
| 2035 Mar. | $410.74 | -0.72% |
| 2035 Apr. | $406.45 | -1.04% |
| 2035 May. | $400.74 | -1.40% |
| 2035 Jun. | $394.50 | -1.56% |
| 2035 Jul. | $389.01 | -1.39% |
| 2035 Aug. | $384.31 | -1.21% |
| 2035 Sep. | $379.19 | -1.33% |
| 2035 Oct. | $372.03 | -1.89% |
| 2035 Nov. | $364.05 | -2.14% |
| 2035 Dec. | $352.16 | -3.27% |
RGEN : Repligen stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $331.02 | -6.00% |
| 2036 Feb. | $302.83 | -8.52% |
| 2036 Mar. | $268.93 | -11.19% |
| 2036 Apr. | $235.22 | -12.53% |
| 2036 May. | $203.39 | -13.53% |
Financial Data for Repligen stock
Frequently Asked Questions about Repligen stock forecast
Is Repligen a good long term stock?
From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to AIPickup, the Repligen stock price forecast for 2026 Jun. is $119.21914119508673 From Repligen stock forecast , Repligen (RGEN) stock can be a good investment choice. According to AIPickup, the Repligen stock price forecast for 2027 May. is $328.211042863256 From Repligen stock forecast , Repligen (RGEN) stock can be a good investment choice. According to AIPickup, the Repligen stock price forecast for 2030 May. is $195.62592135073888 From Repligen stock forecast , Repligen (RGEN) stock can be a good investment choice. According to AIPickup, the Repligen stock price forecast for 2031 May. is $159.94060195451058 From Repligen stock forecast , Repligen (RGEN) stock can be a good investment choice. According to AIPickup, the Repligen stock price forecast for 2035 May. is $400.73826962232545 From Repligen stock forecast , Repligen (RGEN) stock can be a good investment choice. According to AIPickup, the Repligen stock price forecast for 2036 May. is $203.38807544540262
Is Repligen stock overvalued?
Repligen (RGEN) stock is expected to go UP . Therefore, AIPickup would say that Repligen (RGEN) stock is NOT overvalued.
Will Repligen stock price go up?
Yes. The Repligen stock price forecast for 2027 May. is $328.211042863256
Is Repligen stock a good buy now?
Since closing price on 2026-05-28 is $122.7300033569336 and forecast for 2027 May. is $328.21, Repligen stock is a good 1 year investment.
14 Days Historical Data for Repligen stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| RGEN stock price for 2026-05-08 | $123.46 | $125.83 | $121.26 | $126.83 |
| RGEN stock price for 2026-05-11 | $115.91 | $124.18 | $115.60 | $124.72 |
| RGEN stock price for 2026-05-12 | $113.60 | $116.29 | $113.26 | $119.01 |
| RGEN stock price for 2026-05-13 | $107.03 | $113.67 | $106.92 | $115.40 |
| RGEN stock price for 2026-05-14 | $103.38 | $107.03 | $100.99 | $107.75 |
| RGEN stock price for 2026-05-15 | $102.87 | $104.46 | $102.55 | $107.75 |
| RGEN stock price for 2026-05-18 | $104.20 | $103.70 | $102.48 | $106.38 |
| RGEN stock price for 2026-05-19 | $108.52 | $105.00 | $103.50 | $110.10 |
| RGEN stock price for 2026-05-20 | $111.74 | $109.00 | $103.63 | $111.88 |
| RGEN stock price for 2026-05-21 | $113.37 | $110.90 | $109.38 | $114.83 |
| RGEN stock price for 2026-05-22 | $115.06 | $113.50 | $112.37 | $116.00 |
| RGEN stock price for 2026-05-26 | $115.19 | $116.61 | $112.41 | $117.00 |
| RGEN stock price for 2026-05-27 | $113.17 | $115.15 | $112.00 | $118.20 |
| RGEN stock price for 2026-05-28 | $122.73 | $113.17 | $113.04 | $126.68 |